Literature DB >> 7138620

Coronary artery disease in heterozygous familial hypercholesterolemia.

K Hirobe, Y Matsuzawa, K Ishikawa, S Tarui, A Yamamoto, S Nambu, K Fujimoto.   

Abstract

Serum lipids, lipoproteins and Achilles tendon thickness in 52 patients with heterozygous familial hypercholesterolemia (FH) were investigated in order to clarify what are the important factors for the development of coronary artery disease (CAD) in heterozygous FH patients. There were no significant differences in the average concentration of total cholesterol and triglyceride between the patients with and those without CAD. The HDL cholesterol (HDL-C) level was significantly lower in patients with CAD than in those without, and the HDL-C value was within the normal range in most of the patients with heterozygous FH, if not associated with CAD. Although most of the males aged over 50 years had CAD and a decreased level of HDL-C, many of the aged females were without signs of CAD. The HDL-C value of heterozygous FH patients with CAD was significantly lower compared with the age-matched group without CAD. The Achilles tendon was thicker in patients with CAD than in those without CAD, both for males and females, although it was less closely correlated with the incidence of CAD than HDL-C or the atherogenic index. A forecast concerning the development of CAD in heterozygous FH may be possible if we consider multiple parameters, such as HDL-C, atherogenic index, Achilles tendon thickness, etc.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138620     DOI: 10.1016/0021-9150(82)90114-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

Review 1.  Role of lipid-lowering pharmacotherapy in children.

Authors:  S Tonstad
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  A novel approach to screening for familial hypercholesterolemia in a large public venue.

Authors:  Megan Campbell; Jessa Humanki; Heather Zierhut
Journal:  J Community Genet       Date:  2016-11-26

3.  Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia.

Authors:  D D Sugrue; I Trayner; G R Thompson; V J Vere; J Dimeson; Y Stirling; T W Meade
Journal:  Br Heart J       Date:  1985-03

4.  Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice.

Authors:  Marcia L E MacDonald; Roshni R Singaraja; Nagat Bissada; Piers Ruddle; Russell Watts; Joanna M Karasinska; William T Gibson; Catherine Fievet; Jean E Vance; Bart Staels; Michael R Hayden
Journal:  J Lipid Res       Date:  2007-10-24       Impact factor: 5.922

5.  Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia.

Authors:  Bei Wang; Qiuwang Zhang; Ling Lin; Li-Li Pan; Cheng-Yu He; Xiang-Xin Wan; Zhi-Ang Zheng; Zheng-Xin Huang; Chao-Bao Zou; Ming-Chang Fu; Michael J Kutryk
Journal:  Lipids Health Dis       Date:  2018-06-01       Impact factor: 3.876

6.  Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017.

Authors:  Mariko Harada-Shiba; Hidenori Arai; Yasushi Ishigaki; Shun Ishibashi; Tomonori Okamura; Masatsune Ogura; Kazushige Dobashi; Atsushi Nohara; Hideaki Bujo; Katsumi Miyauchi; Shizuya Yamashita; Koutaro Yokote
Journal:  J Atheroscler Thromb       Date:  2018-06-07       Impact factor: 4.928

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.